mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.09 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.09 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.1 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |